Triptodur Kit
Product Images NDC 24338-150

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Triptodur (NDC 24338-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Triptodur 01)

An instructional diagram showing two steps of using a syringe with a vial. The left panel depicts removing the cap from the syringe. The right panel shows the syringe being inserted into the vial with an upward twisting motion to withdraw or mix the contents as part of drug preparation.*

FDA Label Image

Image (Triptodur 02)

An instructional illustration showing how to attach a vial to a syringe. The first part depicts pressing the vial down onto the syringe, while the second part shows twisting the vial to secure it onto the syringe. This image is from the TRIPTODUR kit by Azurity Pharmaceuticals, used for preparing the medication for administration.*

FDA Label Image

Image (Triptodur 03)

An instructional illustration showing two steps for preparing an injection using a syringe. The left panel depicts a hand inserting a needle into the syringe with a downward arrow indicating attachment. The right panel shows a hand pulling off the needle cap with an upward arrow indicating removal.*

FDA Label Image

Image (Triptodur 04)

An instructional illustration showing steps for preparing an injectable medication from a vial. The left panel depicts a hand pushing a syringe needle into a vial stopper vertically downward. The right panel shows a hand pressing the syringe plunger downward while the needle remains inserted in the vial.*

FDA Label Image

Image (Triptodur 05)

An instructional illustration showing hands preparing an injection by drawing liquid from a vial using a syringe. The image demonstrates the step of inserting the syringe needle into a vial, with one hand holding the vial steady and the other hand pulling the plunger.*

FDA Label Image

Image (Triptodur 06)

An instructional illustration showing a hand attaching a syringe to a vial, followed by drawing liquid from the vial into the syringe by pulling down on the plunger. The diagram demonstrates proper preparation technique for medication administration.*

FDA Label Image

Image (Triptodur 07)

Illustration showing hands preparing an injection syringe with a vial. The left panel depicts removing the needle cap from the syringe, and the right panel shows pulling the syringe plunger upwards, presumably to draw medication from the vial. The images emphasize proper syringe handling techniques.*

FDA Label Image

Image (Triptodur 08)

An illustration showing the steps to prepare a syringe using a vial adapter. The first step depicts inserting the adapter into a vial, pressing it down. The second step shows lifting the vial adapter upward, likely to remove it from the vial, while the syringe remains attached below.*

FDA Label Image

Image (Triptodur 09)

An instructional illustration showing hands holding a syringe with a zoomed-in view of the syringe tip. The magnified area highlights the correct syringe condition labeled 'No air,' indicating no air bubbles inside the syringe before administration.*

FDA Label Image

Image (Triptodur 10)

An instructional illustration showing a hand administering an injection into a finger, with an arrow indicating the direction of the syringe into the skin.*

FDA Label Image

Chemical Structure (Triptodur 11)

Chemical structure diagram showing the molecular composition of triptorelin with an additional notation for pamoic acid (C23H16O6) as part of the compound representation. The structure includes multiple rings and peptide bonds consistent with the triptorelin molecule.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Triptodur kit containing triptorelin 22.5 mg for extended-release injectable suspension. The label states usage for intramuscular injection every 24 weeks and includes contents: one single-dose vial, one pre-filled syringe of sterile diluent, and two needles. Distributed by Arbor Pharmaceuticals, Inc., with storage instructions and inactive ingredients listed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.